Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Hayat Pharmaceutical Industries Co Cash Ratio?
Hayat Pharmaceutical Industries CoAMM:HPIC 47 Cash Ratio is 1.70 as of Jun. 2026, which is 24% above its 10-year median of 1.37. GuruFocus rates AMM:HPIC with a GF Score™ of 47/100. The stock has 8 warning signs investors should review. Among 936 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 75.64% on this metric.
Hayat Pharmaceutical Industries Co has a Cash Ratio of 1.70. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
Hayat Pharmaceutical Industries Co (AMM:HPIC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Hayat Pharmaceutical Industries Co Cash Ratio Related Terms
Hayat Pharmaceutical Industries Co Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Cash Ratio Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Cash Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Cash Ratio of 1.70 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 24% above median its historical median of 1.37. Over the past decade, Hayat Pharmaceutical Industries Co's Cash Ratio has ranged from 0.76 to 2.69. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #228 out of 936 companies in the Drug Manufacturers industry, placing it in the top 24.4%.
Is Hayat Pharmaceutical Industries Co's Cash Ratio too high?
Hayat Pharmaceutical Industries Co's current Cash Ratio of 1.70 is 24% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 2.69. The Drug Manufacturers industry median Cash Ratio is 0.59. Hayat Pharmaceutical Industries Co's value of 1.70 is 188.1% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #228 out of 936 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #228 out of 936 companies for Cash Ratio. This places Hayat Pharmaceutical Industries Co in the top 24% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.59. Hayat Pharmaceutical Industries Co's value of 1.70 is 188.1% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Cash Ratio has ranged from 0.76 to 2.69 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 0.59, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.59, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Cash Ratio of 1.70 is 188.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Cash Ratio is 1.70, which is 24% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current Cash Ratio of 1.70. The current Cash Ratio is 1.70, which is 24% above median its 10-year median of 1.37 and 188.1% above the Drug Manufacturers industry median of 0.59. Hayat Pharmaceutical Industries Co's overall GF Score™ is 47/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Cash Ratio is 1.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
47GF Score
Get the complete analysis for AMM:HPIC
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
